Kenvue Inc. is set to be removed from the FTSE All-World Index, a move that can trigger automatic selling from index-tracking funds and reduce a key source of support for the consumer-health company’s shares.
Kenvue to Leave FTSE All-World Index

Index deletions matter because they can force passive managers to sell regardless of fundamentals, often pressuring a stock around the rebalance date as index-linked capital exits and active investors wait for the dust to settle. For Kenvue, the removal comes at a time when the company is already navigating investor scrutiny over growth, margins and whether it can establish a stronger standalone identity after being spun out of Johnson & Johnson.

The decision also shifts Kenvue out of one of the world’s most widely followed benchmark universes, which can narrow the pool of automatic buyers and increase reliance on discretionary investors. That matters for a company whose consumer staples profile typically appeals to income and defensive investors, but whose valuation can still be sensitive to fund flows and sentiment around branded household and personal-care products.
For the broader market, the move is another reminder that benchmark reshuffles can create short-term trading dislocations even when the underlying business story is unchanged. Investors will now focus on how much forced selling is tied to the deletion and whether Kenvue can regain traction through earnings execution and any future index review.
| Entity | Gains | Losses |
|---|---|---|
| Active buyers | ▲Potentially cheaper entry | ▼Near-term volatility |
| Passive index funds | ▲None | ▼Forced selling pressure |
| Kenvue rivals | ▲Relative index attention | ▼None |
| Kenvue shareholders | ▲Possible post-rebalance bounce | ▼Loss of benchmark support |



